tradingkey.logo
tradingkey.logo
Pesquisar

Amneal Pharmaceuticals Inc

AMRX
Adicionar à lista de desejos
12.308USD
-0.082-0.66%
Horário de mercado ETCotações atrasadas em 15 min
3.87BValor de mercado
31.74P/L TTM

Amneal Pharmaceuticals Inc

12.308
-0.082-0.66%

Mais detalhes de Amneal Pharmaceuticals Inc Empresa

Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.

Informações de Amneal Pharmaceuticals Inc

Código da empresaAMRX
Nome da EmpresaAmneal Pharmaceuticals Inc
Data de listagemNov 18, 2009
CEOPatel (Chintu)
Número de funcionários8100
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 18
Endereço400 Crossing Boulevard, 3rd Floor
CidadeBRIDGEWATER
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal08807
Telefone19089473120
Sitehttps://amneal.com/
Código da empresaAMRX
Data de listagemNov 18, 2009
CEOPatel (Chintu)

Executivos da empresa Amneal Pharmaceuticals Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
26.14M
+2.01%
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.64M
+2.12%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
449.43K
-38.37%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
399.79K
+52.12%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
320.80K
+10.85%
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
--
Buchi (J Kevin)
Buchi (J Kevin)
Independent Director
Independent Director
--
--
Mr. Andrew S. Boyer
Mr. Andrew S. Boyer
Executive Vice President, Chief Commercial Officer - Generics
Executive Vice President, Chief Commercial Officer - Generics
--
--
Mr. Chirag Patel
Mr. Chirag Patel
President, Co-Chief Executive Officer, Co-Founder, Director
President, Co-Chief Executive Officer, Co-Founder, Director
--
--
Mr. Ted Nark
Mr. Ted Nark
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
26.14M
+2.01%
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.64M
+2.12%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
449.43K
-38.37%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
399.79K
+52.12%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
320.80K
+10.85%
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Oral solid
726.38M
24.06%
Distribution
408.46M
13.53%
Central Nervous System
333.42M
11.04%
Government label
270.11M
8.95%
Other dosage forms
252.42M
8.36%
Outro
1.03B
34.05%
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Oral solid
726.38M
24.06%
Distribution
408.46M
13.53%
Central Nervous System
333.42M
11.04%
Government label
270.11M
8.95%
Other dosage forms
252.42M
8.36%
Outro
1.03B
34.05%

Distribuição de ações

Atualizado em: há 15 horas
Atualizado em: há 15 horas
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Patel (Tushar Bhikhubhai)
15.23%
Patel (Chintu)
8.19%
Patel (Chirag K)
7.10%
Akram (Mahesh)
6.44%
Patel (Dipan)
5.30%
Outro
57.73%
Investidores
Investidores
Proporção
Patel (Tushar Bhikhubhai)
15.23%
Patel (Chintu)
8.19%
Patel (Chirag K)
7.10%
Akram (Mahesh)
6.44%
Patel (Dipan)
5.30%
Outro
57.73%
Tipos de investidores
Investidores
Proporção
Individual Investor
44.13%
Investment Advisor
19.79%
Investment Advisor/Hedge Fund
12.69%
Hedge Fund
11.08%
Private Equity
3.86%
Research Firm
2.61%
Pension Fund
0.72%
Bank and Trust
0.42%
Sovereign Wealth Fund
0.28%
Outro
4.42%

Participação acionária institucional

Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
521
161.64M
50.67%
-25.72M
2025Q4
448
154.72M
55.65%
+68.38K
2025Q3
455
154.66M
56.61%
+8.55M
2025Q2
432
145.89M
53.25%
+6.99M
2025Q1
416
138.78M
50.16%
-18.42M
2024Q4
398
129.01M
49.64%
-14.17M
2024Q3
380
143.02M
47.07%
+6.97M
2024Q2
372
135.82M
34.71%
+37.56M
2024Q1
356
97.40M
32.81%
-3.83M
2023Q4
348
89.35M
29.61%
+7.08M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Patel (Tushar Bhikhubhai)
48.58M
15.23%
-5.00M
-9.33%
Mar 14, 2025
Patel (Chintu)
26.14M
8.19%
+524.49K
+2.05%
Mar 12, 2026
Patel (Chirag K)
22.66M
7.1%
+535.49K
+2.42%
Mar 12, 2026
Akram (Mahesh)
20.56M
6.44%
-6.30M
-23.45%
Mar 31, 2025
Patel (Dipan)
16.90M
5.3%
-6.92M
-29.06%
Dec 31, 2025
Rubric Capital Management LP
12.33M
3.87%
--
--
Dec 31, 2025
TPG Capital, L.P.
12.33M
3.86%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
11.57M
3.63%
+231.50K
+2.04%
Dec 31, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
Invesco Pharmaceuticals ETF
3.08%
State Street SPDR S&P Pharmaceuticals ETF
2.01%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2%
Invesco Dorsey Wright Healthcare Momentum ETF
0.99%
Invesco Dorsey Wright SmallCap Momentum ETF
0.83%
First Trust NASDAQ Pharmaceuticals ETF
0.78%
First Trust Small Cap Growth AlphaDEX Fund
0.72%
iShares U.S. Pharmaceuticals ETF
0.68%
ProShares Ultra Nasdaq Biotechnology
0.48%
WisdomTree US SmallCap Fund
0.36%
Ver Mais
Invesco Pharmaceuticals ETF
Proporção3.08%
State Street SPDR S&P Pharmaceuticals ETF
Proporção2.01%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proporção2%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporção0.99%
Invesco Dorsey Wright SmallCap Momentum ETF
Proporção0.83%
First Trust NASDAQ Pharmaceuticals ETF
Proporção0.78%
First Trust Small Cap Growth AlphaDEX Fund
Proporção0.72%
iShares U.S. Pharmaceuticals ETF
Proporção0.68%
ProShares Ultra Nasdaq Biotechnology
Proporção0.48%
WisdomTree US SmallCap Fund
Proporção0.36%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI